Solvemed Limited

Solvemed Limited, founded in 2021, is a venture capital-supported company revolutionizing neurological healthcare with the power of Artificial Intelligence. The company's slogan "Revolutionising neurology diagnostics and drug discovery with the power of Artificial Intelligence" encapsulates its mission to bring innovation to the field of Neuroscience AI. Solvemed focuses on critical care, leveraging its exclusive machine learning technology to develop cutting-edge digital pupillometry and eye-movement clinical examination tools, along with remote monitoring capabilities. This innovative approach aims to enhance patient care and treatment results while potentially optimizing healthcare systems' processes and workflows. The company recently secured a significant milestone with a £3.20M Seed Round investment on 05 October 2023. This investment came from a syndicate of notable venture capital firms including Apex Ventures, Preface Ventures, Sunfish Partners, and Tensor Ventures. With its headquarters in the United Kingdom, Solvemed presents a compelling opportunity for investors looking to support the next wave of AI-driven innovation in the healthcare industry.